<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>26(9)</volume><submitter>van Zeeland M</submitter><journal>The breast journal</journal><pagination>1869-1870</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7586789</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Omission of axillary lymph node dissection after neoadjuvant chemotherapy for clinically node-positive breast cancer: How can we select patients?</pubmed_title><pmcid>PMC7586789</pmcid><pubmed_authors>Laurens N</pubmed_authors><pubmed_authors>Wauters C</pubmed_authors><pubmed_authors>Westhoff P</pubmed_authors><pubmed_authors>Bult P</pubmed_authors><pubmed_authors>Strobbe L</pubmed_authors><pubmed_authors>Werner A</pubmed_authors><pubmed_authors>Meijer H</pubmed_authors><pubmed_authors>van Zeeland M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Omission of axillary lymph node dissection after neoadjuvant chemotherapy for clinically node-positive breast cancer: How can we select patients?</name><description/><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Sep</publication><modification>2025-04-25T22:48:38.774Z</modification><creation>2025-04-06T09:10:01.463Z</creation></dates><accession>S-EPMC7586789</accession><cross_references><pubmed>32524674</pubmed><doi>10.1111/tbj.13930</doi></cross_references></HashMap>